Wire Stories
572Intelsat Commercial Aviation goes into Agreement with Nelco to Offer Inflight Connectivity in India’s Airspace
Intelsat enters India’s untapped commercial airline market MCLEAN, Va. and MUMBAI, India–(BUSINESS WIRE)–Intelsat, operator of one of the world’s largest integrated satellite...
- 516
FIS to Modernize Real-Time Payments Infrastructure and Central Bank Digital Currencies for Countries Around the World
Key facts FIS is now offering a central infrastructure payment solution through RealNet™ Central, which enables countries to modernize or build their...
- 510
Biocytogen Expands Partnership with Merck KGaA, Darmstadt, Germany
BEIJING & DARMSTADT, Germany–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for...
- 511
Nighthawk Gold Completes 2022 Exploration Program Drilling Ahead of Schedule
TORONTO–(BUSINESS WIRE)–$MIMZF #commodities–Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK; OTCQX: MIMZF) is pleased to report the completion of its 2022...
- 557
Avanci Signs Agreements with Hyundai and Kia
South Korean automakers join Avanci’s essential patent marketplace for connected vehicles DALLAS–(BUSINESS WIRE)–Today, Avanci announced that it has signed patent license agreements...
- 482
Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
The 25-week weight loss study which achieved its previously reported primary endpoints also examined the effects of GS200 on insulin resistance BOSTON–(BUSINESS...
- 488
Grab Reports Second Quarter 2022 Results
Q2 record Revenue of $321 million, up 79% year-over-year Q2 GMV of $5.1 billion, up 30% year-over-year Q2 Loss for the period...
- 558
Genius Group Enters into a Securities Purchase Agreement for US$18.13 Million Private Placement
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group, has entered...
- 582
LYNPARZA® (olaparib) Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the...
- 526
Hansen Powers Customer Care and Billing for Allente
MELBOURNE, Australia–(BUSINESS WIRE)–Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water and communications industries, is pleased...
